DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Saad F, Cella D, Basch E. et al.
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.
Lancet Oncol 2018;
19: 1404-1416
DOI: 10.1016/S1470-2045(18)30456-X.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.